The human AML cell lines PLB-985 and OCI-AML3 co-expressed NOX2 and H2R (Figures 1A,F) and were employed in the assessment of the pro-differentiating effects of HDC on monocytic AML cells. The gene discussed is HRH2; the disease is acute myeloid leukemia.